MedTech Expo 2025: ICMR licenses nine technologies to 17 industry partners
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus
Center of Excellence for Molecular Diagnostics and Proteomics will enable affordable diagnostics for infectious diseases in India
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Subscribe To Our Newsletter & Stay Updated